These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 26996987)

  • 21. Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data.
    Debelak K; Morrone WR; O'Grady KE; Jones HE
    Am J Addict; 2013; 22(3):252-4. PubMed ID: 23617867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substance use in pregnancy.
    Wong S; Ordean A; Kahan M; ; ; ; ;
    J Obstet Gynaecol Can; 2011 Apr; 33(4):367-384. PubMed ID: 21501542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Maternal Buprenorphine or Methadone Dose with Fetal Growth Indices and Neonatal Abstinence Syndrome.
    Coulson CC; Lorencz E; Rittenhouse K; Ramage M; Lorenz K; Galvin SL
    Am J Perinatol; 2021 Jan; 38(1):28-36. PubMed ID: 31421639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
    Kelty E; Hulse G
    Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neonatal Abstinence Syndrome: Update on Diagnostic and Therapeutic Strategies.
    Raffaeli G; Cavallaro G; Allegaert K; Wildschut ED; Fumagalli M; Agosti M; Tibboel D; Mosca F
    Pharmacotherapy; 2017 Jul; 37(7):814-823. PubMed ID: 28519244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
    Kakko J; Heilig M; Sarman I
    Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prenatal exposure to opioid maintenance treatment and neonatal outcomes: Nationwide registry studies from the Czech Republic and Norway.
    Handal M; Nechanská B; Skurtveit S; Lund IO; Gabrhelík R; Engeland A; Mravčík V
    Pharmacol Res Perspect; 2019 Oct; 7(5):e00501. PubMed ID: 31428431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioid Addiction in Pregnancy: Does Depression Negatively Impact Adherence With Prenatal Care?
    Hensley L; Sulo S; Kozmic S; Parilla BV
    J Addict Med; 2018; 12(1):61-64. PubMed ID: 29068826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Buprenorphine for the treatment of opioid dependence in pregnancy.
    Mittal L
    J Perinat Neonatal Nurs; 2014; 28(3):178-84. PubMed ID: 25062519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neonatal opioid withdrawal syndrome.
    Sutter MB; Leeman L; Hsi A
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):317-34. PubMed ID: 24845493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Buprenorphine Versus Methadone for Opioid Dependence in Pregnancy.
    Noormohammadi A; Forinash A; Yancey A; Crannage E; Campbell K; Shyken J
    Ann Pharmacother; 2016 Aug; 50(8):666-72. PubMed ID: 27199497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Buprenorphine Initiation and Linkage to Outpatient Buprenorphine do not Reduce Frequency of Injection Opiate Use Following Hospitalization.
    Cushman PA; Liebschutz JM; Anderson BJ; Moreau MR; Stein MD
    J Subst Abuse Treat; 2016 Sep; 68():68-73. PubMed ID: 27431049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Buprenorphine and Naloxone Versus Buprenorphine for Opioid Use Disorder in Pregnancy: A Cohort Study.
    Mullins N; Galvin SL; Ramage M; Gannon M; Lorenz K; Sager B; Coulson CC
    J Addict Med; 2020; 14(3):185-192. PubMed ID: 31567599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioids in pregnancy and neonatal abstinence syndrome.
    Stover MW; Davis JM
    Semin Perinatol; 2015 Nov; 39(7):561-5. PubMed ID: 26452318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioid dependence and pregnancy: minimizing stress on the fetal brain.
    McCarthy JJ; Leamon MH; Finnegan LP; Fassbender C
    Am J Obstet Gynecol; 2017 Mar; 216(3):226-231. PubMed ID: 27729254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of Preterm Birth in the Association Between Opioid Maintenance Therapy and Neonatal Abstinence Syndrome.
    Lemon LS; Naimi A; Caritis SN; Platt RW; Venkataramanan R; Bodnar LM
    Paediatr Perinat Epidemiol; 2018 Mar; 32(2):213-222. PubMed ID: 29372750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of the pregnant opiate user.
    Gerada C; Dawe S; Farrell M
    Br J Hosp Med; 1990 Feb; 43(2):138-41. PubMed ID: 2310887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of substitution therapy on the birth weight of the newborn, its postpartum adaptation, trophic and course of the neonatal abstinence syndrome].
    Vavrinková B; Binder T
    Ceska Gynekol; 2007 Aug; 72(4):247-53. PubMed ID: 17966605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternal Opioid Treatment: Human Experimental Research (MOTHER) Study: maternal, fetal and neonatal outcomes from secondary analyses.
    Bandstra ES
    Addiction; 2012 Nov; 107 Suppl 1():1-4. PubMed ID: 23106922
    [No Abstract]   [Full Text] [Related]  

  • 40. Conceptualizing Neonatal Abstinence Syndrome as a Cascade of Care: A Qualitative Study With Healthcare Providers in Ohio.
    Syvertsen JL; Toneff H; Madden DR; Clapp JD
    Adv Neonatal Care; 2018 Dec; 18(6):488-499. PubMed ID: 30234507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.